# Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

> **NCT01163084** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 10 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Stage IIA Prostate Cancer AJCC v7
- Stage IIB Prostate Cancer AJCC v7

## Interventions

- **DRUG:** Goserelin Acetate
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Leuprolide Acetate
- **DRUG:** Vismodegib

## Key facts

- **NCT ID:** NCT01163084
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07-09
- **Primary completion:** 2012-06-01
- **Final completion:** 2012-06-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163084, "Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01163084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*